These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27982017)

  • 1. Extracellular vesicle-mediated suicide mRNA/protein delivery inhibits glioblastoma tumor growth in vivo.
    Erkan EP; Senfter D; Madlener S; Jungwirth G; Ströbel T; Saydam N; Saydam O
    Cancer Gene Ther; 2017 Jan; 24(1):38-44. PubMed ID: 27982017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suicide gene therapy with an adenovirus expressing the fusion gene CD::UPRT in human glioblastomas: different sensitivities correlate with p53 status.
    Bourbeau D; Lavoie G; Nalbantoglu J; Massie B
    J Gene Med; 2004 Dec; 6(12):1320-32. PubMed ID: 15515126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic properties of tumour cells have a key impact on the bystander effect mediated by genetically engineered mesenchymal stromal cells.
    Matuskova M; Baranovicova L; Kozovska Z; Durinikova E; Pastorakova A; Hunakova L; Waczulikova I; Nencka R; Kucerova L
    J Gene Med; 2012 Dec; 14(12):776-87. PubMed ID: 23150190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suicide gene therapy with the yeast fusion gene cytosine deaminase/uracil phosphoribosyltransferase is not enough for pancreatic cancer.
    Fogar P; Navaglia F; Basso D; Greco E; Zambon CF; Fadi E; Falda A; Stranges A; Vannozzi F; Danesi R; Pedrazzoli S; Plebani M
    Pancreas; 2007 Oct; 35(3):224-31. PubMed ID: 17895842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine.
    Koyama F; Sawada H; Hirao T; Fujii H; Hamada H; Nakano H
    Cancer Gene Ther; 2000 Jul; 7(7):1015-22. PubMed ID: 10917204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Vesicles as Carriers of Suicide mRNA and/or Protein in Cancer Therapy.
    Erkan EP; Saydam N; Chen CC; Saydam O
    Methods Mol Biol; 2019; 1895():87-96. PubMed ID: 30539531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracellular prodrug gene therapy for cancer mediated by tumor cell suicide gene exosomes.
    Altanerova U; Jakubechova J; Benejova K; Priscakova P; Repiska V; Babelova A; Smolkova B; Altaner C
    Int J Cancer; 2021 Jan; 148(1):128-139. PubMed ID: 32621791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth.
    Setti M; Osti D; Richichi C; Ortensi B; Del Bene M; Fornasari L; Beznoussenko G; Mironov A; Rappa G; Cuomo A; Faretta M; Bonaldi T; Lorico A; Pelicci G
    Oncotarget; 2015 Oct; 6(31):31413-27. PubMed ID: 26429879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human adipose tissue-derived mesenchymal stem cells expressing yeast cytosinedeaminase::uracil phosphoribosyltransferase inhibit intracerebral rat glioblastoma.
    Altanerova V; Cihova M; Babic M; Rychly B; Ondicova K; Mravec B; Altaner C
    Int J Cancer; 2012 May; 130(10):2455-63. PubMed ID: 21732344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity.
    Kaliberov SA; Chiz S; Kaliberova LN; Krendelchtchikova V; Della Manna D; Zhou T; Buchsbaum DJ
    Cancer Gene Ther; 2006 Feb; 13(2):203-14. PubMed ID: 16082379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment, based on lysomustine administration with mesenchymal stem cells expressing cytosine deaminase therapy, leads to pronounced murine Lewis lung carcinoma growth inhibition.
    Krassikova LS; Karshieva SS; Cheglakov IB; Belyavsky AV
    J Gene Med; 2016 Sep; 18(9):220-33. PubMed ID: 27461566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically engineered microvesicles carrying suicide mRNA/protein inhibit schwannoma tumor growth.
    Mizrak A; Bolukbasi MF; Ozdener GB; Brenner GJ; Madlener S; Erkan EP; Ströbel T; Breakefield XO; Saydam O
    Mol Ther; 2013 Jan; 21(1):101-8. PubMed ID: 22910294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental gene therapy for brain tumors using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene with 5-fluorocytosine.
    Adachi Y; Tamiya T; Ichikawa T; Terada K; Ono Y; Matsumoto K; Furuta T; Hamada H; Ohmoto T
    Hum Gene Ther; 2000 Jan; 11(1):77-89. PubMed ID: 10646641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human amniotic fluid-derived stem cells expressing cytosine deaminase and thymidine kinase inhibits the growth of breast cancer cells in cellular and xenograft mouse models.
    Kang NH; Hwang KA; Yi BR; Lee HJ; Jeung EB; Kim SU; Choi KC
    Cancer Gene Ther; 2012 Jun; 19(6):412-9. PubMed ID: 22498724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Vesicle-Mediated
    Forterre AV; Wang JH; Delcayre A; Kim K; Green C; Pegram MD; Jeffrey SS; Matin AC
    Mol Cancer Ther; 2020 Mar; 19(3):858-867. PubMed ID: 31941722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effects of genetically engineered stem cells expressing cytosine deaminase and interferon-β via their tumor tropism to selectively target human hepatocarcinoma cells.
    Yi BR; Hwang KA; Kang NH; Kim SU; Jeung EB; Kim HC; Choi KC
    Cancer Gene Ther; 2012 Sep; 19(9):644-51. PubMed ID: 22790964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379.
    O'Brien KP; Khan S; Gilligan KE; Zafar H; Lalor P; Glynn C; O'Flatharta C; Ingoldsby H; Dockery P; De Bhulbh A; Schweber JR; St John K; Leahy M; Murphy JM; Gallagher WM; O'Brien T; Kerin MJ; Dwyer RM
    Oncogene; 2018 Apr; 37(16):2137-2149. PubMed ID: 29367765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo preclinical low-field MRI monitoring of tumor growth following a suicide-gene therapy in an orthotopic mice model of human glioblastoma.
    Breton E; Goetz C; Kintz J; Accart N; Aubertin G; Grellier B; Erbs P; Rooke R; Constantinesco A; Choquet P
    C R Biol; 2010 Mar; 333(3):220-5. PubMed ID: 20338540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete regression of glioblastoma by mesenchymal stem cells mediated prodrug gene therapy simulating clinical therapeutic scenario.
    Altaner C; Altanerova V; Cihova M; Ondicova K; Rychly B; Baciak L; Mravec B
    Int J Cancer; 2014 Mar; 134(6):1458-65. PubMed ID: 24038033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice.
    Kucerova L; Matuskova M; Pastorakova A; Tyciakova S; Jakubikova J; Bohovic R; Altanerova V; Altaner C
    J Gene Med; 2008 Oct; 10(10):1071-82. PubMed ID: 18671316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.